Pimozide (Par Pharmaceutical Inc.)


Welcome to the PulseAid listing for the Pimozide drug offered from Par Pharmaceutical Inc.. This Typical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Inc.
NON-PROPRIETARY NAME: Pimozide
SUBSTANCE NAME: PIMOZIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Typical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-09-28
END MARKETING DATE: 0000-00-00


Pimozide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPimozide from Par Pharmaceutical Inc.
LABELER NAME: Par Pharmaceutical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2015-09-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-347_f649805a-d143-4691-8a2e-66dcf1f3837a
PRODUCT NDC: 49884-347
APPLICATION NUMBER: ANDA204521

Other PIMOZIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalPimozide
Par Pharmaceutical Inc.Pimozide
Teva Select BrandsORAP